EN
Bladder cancer often announces itself quietly: blood appears in the urine without pain and disappears again, and it is easily put down to an infection. A course of antibiotics follows, the symptom passes and the cause remains. So people often come to the question of treatment in Germany once a diagnosis has been made but doubts remain — how deeply the tumour has grown and whether the bladder can be kept. That is exactly where the German approach places its emphasis.
What people arrive with
The key question with a bladder tumour is whether it has grown into the muscle layer of the wall or is still superficial. Literally everything depends on that: the extent of the treatment and whether the organ can be preserved. Most tumours are superficial at the time they are found, which is good news — but that can be confirmed only by accurate assessment, not from symptoms.
How the diagnosis is confirmed
It starts simply — a urine test, including cytology, in which the urine is checked for tumour cells, and ultrasound. The main method is cystoscopy: a thin instrument with a camera is passed through the urethra and the wall of the bladder is examined from inside. German hospitals often use fluorescence cystoscopy: a substance introduced into the bladder makes tumour tissue glow under a special light, so that even small and flat lesions can be seen which ordinary light might miss.
The diagnosis and the stage are established by transurethral resection: the tumour is removed through the urethra and the removed tissue is examined by a pathologist. It is the pathologist who determines the type of tumour, its grade and — most important — whether it has penetrated the muscle layer. CT or MRI is added where the spread has to be assessed. Thus the resection is at once diagnosis and the first stage of treatment.
Which approaches are used
If the tumour is superficial, the resection is most often enough, followed by local treatment placed directly into the bladder. A chemotherapy solution or BCG vaccine, which triggers a local immune response against the remaining cells, is instilled into the bladder. That approach is gentle: the drug acts inside the bladder and barely touches the rest of the body. Follow-up is then done regularly by cystoscopy — with this tumour it matters to notice any return in time.
If the tumour has grown into the muscle layer, the approach is more serious. One of the main options is removal of the bladder (cystectomy) followed by creating a new route for the urine; in some cases a reservoir replacing the bladder is formed from a section of bowel. As an alternative, an organ-preserving approach is considered for selected patients — a combination of resection, chemotherapy and radiotherapy. Drug therapy, including immunotherapy chosen by the features of the tumour, is often used before and after the operation. What is suitable is decided by a board — urologist, oncologist and radiation oncologist together.
A second opinion
Between “remove the bladder” and “try to preserve it” lies a difficult decision, and it is worth weighing with a doctor who manages such cases often. A German specialist reviews the resection result and the histology, the cystoscopy findings and the images, and says whether they agree with the assessment of the depth of invasion and with the plan. Sometimes that is what determines whether a person keeps their own bladder.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.